| Year |
Citation |
Score |
| 2021 |
Leavey PJ, Laack NN, Krailo MD, Buxton A, Randall RL, DuBois SG, Reed DR, Grier HE, Hawkins DS, Pawel B, Nadel H, Womer RB, Letson GD, Bernstein M, Brown K, et al. Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100358. PMID 34652968 DOI: 10.1200/JCO.21.00358 |
0.365 |
|
| 2021 |
Collier AB, Krailo MD, Dang HM, DuBois SG, Hawkins DS, Bernstein ML, Bomgaars LR, Reed DR, Gorlick RG, Janeway KA. Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group. Pediatric Blood & Cancer. e29333. PMID 34496122 DOI: 10.1002/pbc.29333 |
0.418 |
|
| 2019 |
Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. European Journal of Cancer (Oxford, England : 1990). 109: 36-50. PMID 30685685 DOI: 10.1016/J.Ejca.2018.11.027 |
0.322 |
|
| 2016 |
Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KL, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. The Lancet. Oncology. PMID 27569442 DOI: 10.1016/S1470-2045(16)30214-5 |
0.412 |
|
| 2016 |
Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. 63: 54-61. PMID 26398490 DOI: 10.1002/Pbc.25753 |
0.345 |
|
| 2016 |
Forbrigger Z, Digout C, Fernandez C, Bernstein M, Kulkarni K. Significantly Inferior Overall and Event Free Survival in Pediatric Oncology Patients with Symptomatic Venous Thrombotic Events As Compared to Those without Symptomatic Venous Thrombotic Events: A Population Based Study from Maritimes, Canada Blood. 128: 393-393. DOI: 10.1182/blood.v128.22.393.393 |
0.445 |
|
| 2015 |
Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, ... ... Bernstein ML, et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26304893 DOI: 10.1200/JCO.2014.59.5256 |
0.416 |
|
| 2015 |
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, ... ... Bernstein M, et al. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26033801 DOI: 10.1200/Jco.2014.60.0734 |
0.347 |
|
| 2015 |
Smeland S, Whelan J, Bielack SS, Marina N, Jovic G, Butterfass-Bahloul T, Calaminus G, Eriksson M, Gelderblom H, Gorlick RG, Hogendoorn PCW, Hook J, Kager L, Krailo MD, Kühne T, ... ... Bernstein ML, et al. Event-free survival and overall survival in 2,253 patients with osteosarcoma registered to EURAMOS-1 Journal of Clinical Oncology. 33: 10512-10512. DOI: 10.1200/Jco.2015.33.15_Suppl.10512 |
0.363 |
|
| 2014 |
Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric Blood & Cancer. 61: 1558-64. PMID 24753182 DOI: 10.1002/Pbc.25074 |
0.347 |
|
| 2013 |
Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G. Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). Journal of Pediatric Hematology/Oncology. 35: 509-13. PMID 23887024 DOI: 10.1097/Mph.0B013E31829F3235 |
0.308 |
|
| 2013 |
Goldsby RE, Fan TM, Villaluna D, Wagner LM, Isakoff MS, Meyer J, Randall RL, Lee S, Kim G, Bernstein M, Gorlick R, Krailo M, Marina N. Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. European Journal of Cancer (Oxford, England : 1990). 49: 2384-91. PMID 23664013 DOI: 10.1016/J.Ejca.2013.03.018 |
0.412 |
|
| 2013 |
Felgenhauer JL, Nieder ML, Krailo MD, Bernstein ML, Henry DW, Malkin D, Baruchel S, Chuba PJ, Sailer SL, Brown K, Ranganathan S, Marina N. A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893. Pediatric Blood & Cancer. 60: 409-14. PMID 23065953 DOI: 10.1002/Pbc.24328 |
0.434 |
|
| 2012 |
Ebb D, Meyers P, Grier H, Bernstein M, Gorlick R, Lipshultz SE, Krailo M, Devidas M, Barkauskas DA, Siegal GP, Ferguson WS, Letson GD, Marcus K, Goorin A, Beardsley P, et al. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2545-51. PMID 22665540 DOI: 10.1200/Jco.2011.37.4546 |
0.449 |
|
| 2010 |
O'Brien MM, Lacayo NJ, Lum BL, Kshirsagar S, Buck S, Ravindranath Y, Bernstein M, Weinstein H, Chang MN, Arceci RJ, Sikic BI, Dahl GV. Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: A report from the children's oncology group Pediatric Blood and Cancer. 54: 694-702. PMID 20209646 DOI: 10.1002/Pbc.22366 |
0.373 |
|
| 2009 |
Marina N, Bielack S, Whelan J, Smeland S, Krailo M, Sydes MR, Butterfass-Bahloul T, Calaminus G, Bernstein M. International collaboration is feasible in trials for rare conditions: The EURAMOS experience Cancer Treatment and Research. 152: 339-353. PMID 20213400 DOI: 10.1007/978-1-4419-0284-9_18 |
0.319 |
|
| 2008 |
Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 51: 334-8. PMID 18506764 DOI: 10.1002/Pbc.21618 |
0.429 |
|
| 2008 |
Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 633-8. PMID 18235123 DOI: 10.1200/Jco.2008.14.0095 |
0.423 |
|
| 2008 |
Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PC. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 50: 254-8. PMID 17262795 DOI: 10.1002/Pbc.21132 |
0.318 |
|
| 2007 |
Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. Cancer. 110: 1542-50. PMID 17705175 DOI: 10.1002/Cncr.22961 |
0.354 |
|
| 2007 |
Leavey P, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Bernstein M, Granowetter L, Grier H. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence Journal of Clinical Oncology. 25: 10011-10011. DOI: 10.1200/Jco.2007.25.18_Suppl.10011 |
0.414 |
|
| 2006 |
Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H. Ewing's sarcoma family of tumors: Current management Oncologist. 11: 503-519. PMID 16720851 DOI: 10.1634/theoncologist.11-5-503 |
0.361 |
|
| 2006 |
Bernstein ML, Devidas M, Lafreniere D, Souid AK, Meyers PA, Gebhardt M, Stine K, Nicholas R, Perlman EJ, Dubowy R, Wainer IW, Dickman PS, Link MP, Goorin A, Grier HE, et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 152-9. PMID 16382125 DOI: 10.1200/JCO.2005.02.1717 |
0.402 |
|
| 2006 |
Champagne MA, Fu C, Chang M, Cooley L, Heerema NA, Wood C, French ME, Smith FO, Bernstein ML. Imatinib in Children with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CP CML): AAML0123 COG Study. Blood. 108: 2140-2140. DOI: 10.1182/Blood.V108.11.2140.2140 |
0.438 |
|
| 2005 |
Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, Blaney S, Hershon L, Zhou T, Chen Z, Kretschmar C. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatric Blood & Cancer. 45: 644-8. PMID 16110498 DOI: 10.1002/Pbc.20382 |
0.347 |
|
| 2005 |
Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the children's oncology group Journal of Clinical Oncology. 23: 3376-3382. PMID 15908649 DOI: 10.1200/Jco.2005.03.426 |
0.329 |
|
| 2005 |
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2004-11. PMID 15774791 DOI: 10.1200/Jco.2005.06.031 |
0.346 |
|
| 2005 |
Horton TM, Blaney SM, Langevin AM, Kuhn J, Kamen B, Berg SL, Bernstein M, Weitman S. Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: A pediatric oncology group study Clinical Cancer Research. 11: 1884-1889. PMID 15756014 DOI: 10.1158/1078-0432.CCR-04-1676 |
0.388 |
|
| 2005 |
Dalle JH, Moghrabi A, Rousseau P, Leclerc JM, Barrette S, Bernstein ML, Champagne J, David M, Demers J, Duval M, Hume H, Meyer P, Champagne MA. Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols. Journal of Pediatric Hematology/Oncology. 27: 73-9. PMID 15701980 DOI: 10.1097/01.mph.0000152860.97998.32 |
0.513 |
|
| 2004 |
Aquino VM, Weittnan SD, Winick NJ, Blaney S, Furman WL, Kepner JL, Bonate P, Krailo M, Qu W, Bernstein M. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: A pediatric oncology group study Journal of Clinical Oncology. 22: 1413-1419. PMID 15084615 DOI: 10.1200/Jco.2004.07.111 |
0.316 |
|
| 2004 |
Dalle JH, Duval M, Moghrabi A, Wagner E, Vachon MF, Barrette S, Bernstein M, Champagne J, David M, Demers J, Rousseau P, Winikoff R, Champagne MA. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow Bone Marrow Transplantation. 33: 605-611. PMID 14743192 DOI: 10.1038/sj.bmt.1704433 |
0.419 |
|
| 2003 |
Dalle J, Duval M, Mogbrabi A, Rousseau P, Wagner E, Vachon M, Barrette S, Bernstein M, Champagne J, David M, Demers J, Champagne M. 46 Comparative outcome of unrelated hematopoietic stem cell transplantation (HSCT) with cord blood (CB) vs bone marrow (BM) in pediatric recipients Biology of Blood and Marrow Transplantation. 9: 78-79. DOI: 10.1016/S1083-8791(03)80047-2 |
0.32 |
|
| 2002 |
Ogden AK, Pollock BH, Bernstein ML, Camitta B, Buchanan GR. Intermediate-dose methotrexate and intravenous 6-mercaptopurine chemotherapy for children with acute lymphoblastic leukemia who did not respond to initial induction therapy. Journal of Pediatric Hematology/Oncology. 24: 182-7. PMID 11990303 DOI: 10.1097/00043426-200203000-00005 |
0.365 |
|
| 2001 |
Saylors RL, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 3463-9. PMID 11481351 |
0.302 |
|
| 1997 |
Bernstein ML, Abshire TC, Pollock BH, Devine S, Toledano S, Steuber CP, Bowman WP, Buchanan GR. Idarubicin and cytosine arabinoside reinduction therapy for children with multiple recurrent or refractory acute lymphoblastic leukemia: a Pediatric Oncology Group study. Journal of Pediatric Hematology/Oncology. 19: 68-72. PMID 9065722 DOI: 10.1097/00043426-199701000-00010 |
0.376 |
|
| 1993 |
Bernstein ML, Whitehead VM, Devine S, Grier H, Kung F, Krischer J, Dreyer Z, Bell B, Land V, Buchanan GR. Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study. Cancer. 72: 1790-4. PMID 8348510 |
0.361 |
|
| 1986 |
Bernstein ML, Vekemans MJ. Chromosomal changes in secondary leukemias of childhood and young adulthood. Critical Reviews in Oncology/Hematology. 5: 325-60. PMID 3533293 DOI: 10.1016/S1040-8428(86)80002-6 |
0.384 |
|
| 1986 |
Bernstein ML, Reece ER, de Chadarévian JP, Koch PA. Bone marrow transplantation in lymphomatoid granulomatosis. Report of a case. Cancer. 58: 969-72. PMID 3521844 |
0.317 |
|
| 1986 |
Bernstein ML, Schwartz S. Mandibular relapse in acute leukemia. Report of a case. The American Journal of Pediatric Hematology/Oncology. 8: 240-4. PMID 3490189 |
0.448 |
|
| Show low-probability matches. |